A simple immunohistochemical bio-profile incorporating Bcl2 curbs those cases of invasive breast carcinoma for which an Oncotype Dx characterization is needed.
<h4>Aim</h4>Our goal has been to evaluate the importance that the incorporation of Bcl2 in the ER/PGR/Her2/Ki67 bio-profile can have as predictor of the Oncotype Dx categories.<h4>Material and methods</h4>156 consecutive cases of HR+/Her2- pN0/1 primary breast carcinoma were...
Main Authors: | Claudio Ceccarelli, Antonio De Leo, Pasquale Chieco, Claudio Zamagni, Alice Zamagni, Daniela Rubino, Mario Taffurelli, Donatella Santini |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2019-01-01
|
Series: | PLoS ONE |
Online Access: | https://doi.org/10.1371/journal.pone.0217937 |
Similar Items
-
Relevance of progesterone receptor immunohistochemical staining to Oncotype DX recurrence score
by: Lubna N. Chaudhary, et al.
Published: (2016-06-01) -
Oncotype DX: Where Does It Stand in India?
by: Atul Batra, et al.
Published: (2019-07-01) -
Oncotype Dx Results in Multiple Primary Breast Cancers
by: Michael J. Toole, et al.
Published: (2014-01-01) -
Oncotype Dx Results in Multiple Primary Breast Cancers
by: Michael J. Toole, et al.
Published: (2014-01-01) -
Utilization of Oncotype DX in an Inner City Population: Race or Place?
by: Amber A. Guth, et al.
Published: (2013-01-01)